Prolung, Inc. Presents Highest Combined Sensitivity And Specificity Values For A Truly Non-Invasive Lung Cancer Solution Pursuing FDA Clearance At ISRD & ATS Joint Medical Conference
SALT LAKE CITY, UT / ACCESSWIRE / October 31, 2019 / ProLung, Inc. ("ProLung" or the "Company") and its long-time...